NCT00380822已完成3 期
Double-Blind Study of Miglitol in Japanese With type2 Diabetes
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 27
研究概览
简要总结
To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 69 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type2 diabetic patient on Dietary Therapy
- •Criteria for postprandial plasma glucose and HbA1c are met
排除标准
- •Type1 diabetes
- •Patients treated with antidiabetic drugs or Insulin
研究者
研究点 (27)
Loading locations...
相似试验
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentType 2 Diabetes MellitusNCT00213070Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334399Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
2 期
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)Diabetic NephropathiesNCT01968668Bayer96
已完成
4 期
A randomized controlled trial of Ipragliflozin and sitagliptiType 2 diabetesJPRN-jRCTs031180205Sone Hirohito115
已完成
3 期
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesGlucose Metabolism DisordersMetabolic DiseaseEndocrine System DiseasesHypoglycemic AgentsType 2 Diabetes Mellitus (T2DM)Diabetes MellitusDiabetes Mellitus, Type 2NCT04809220Eli Lilly and Company591